1{
2 "request_info": {
3 "success": true,
4 "credits_used": 1,
5 "credits_used_this_request": 1,
6 "credits_remaining": 19999,
7 "credits_reset_at": "2021-01-01T00:00:00.000Z"
8 },
9 "search_metadata": {
10 "created_at": "2021-01-01T00:00:00.000Z",
11 "processed_at": "2021-01-01T00:00:00.000Z",
12 "total_time_taken": 1.5,
13 "engine_url": "https://www.google.com/scholar?q=rubifen",
14 "html_url": "https://api.serpwow.com/live/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=html",
15 "json_url": "https://api.serpwow.com/live/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=json"
16 },
17 "search_parameters": {
18 "q": "rubifen",
19 "location": "United States",
20 "search_type": "scholar",
21 "engine": "google"
22 },
23 "search_information": {
24 "original_query_yields_zero_results": false,
25 "query_displayed": "rubifen"
26 },
27 "scholar_results": [
28 {
29 "position": 1,
30 "title": "[PDF][PDF] fárMaco de prueba",
31 "link": "http://www.pharmavita.cl/wp-content/uploads/2014/09/Brochure_RubifenPortada.pdf",
32 "domain": "www.pharmavita.cl",
33 "displayed_link": "I VIVo - pharmavita.cl",
34 "snippet": "… RuBIFEN® (Metilfenidato) puede ad- ministrarse tanto en presencia como en ausencia de\nalimentos junto con líquido … nota: puede ser conveniente suspender periódicamente el\ntratamiento con RuBI- FEN® (Metilfenidato) para evaluar el estado del niño",
35 "cited_by_count": 188,
36 "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
37 "pdf_link": "https://diabetesjournals.org/diabetes/article-pdf/62/10/3307/569495/3307.pdf",
38 "versions_count": 4,
39 "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
40 },
41 {
42 "position": 2,
43 "title": "[HTML][HTML] MEDICINES ADVERSE REACTIONS COMMITTEE 20 March 2008 MEETING MINUTES",
44 "link": "https://medsafe.govt.nz/profs/adverse/Minutes133.htm",
45 "domain": "medsafe.govt.nz",
46 "displayed_link": "T Maling, H Kingston, F McClure, D Reith, L Bryant… - medsafe.govt.nz",
47 "snippet": "… 2.1.2 Rubifen SR (methylphenidate SR) brand switch - aggressive and defiant behavioural\nreactions December 2007 minute item 2.1.2, September 2007 minute item 3.2. Issue … Medsafe\nsought further information from the Rubifen product sponsor including the following",
48 "cited_by_count": 188,
49 "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
50 "versions_count": 4,
51 "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
52 },
53 {
54 "position": 3,
55 "title": "Análisis de minimización de costes y del impacto sobre el presupuesto del Sistema Nacional de Salud del tratamiento del trastorno por déficit de atención con …",
56 "link": "https://link.springer.com/content/pdf/10.1007/BF03320877.pdf",
57 "domain": "link.springer.com",
58 "displayed_link": "C Rubio-Terrés, D Rubio-Rodríguez… - … Spanish Research Articles, 2012 - Springer",
59 "snippet": "… Resumen Introducción: No hay evidencia científica de diferencias significativas de efi- cacia\no tolerabilidad entre el metilfenidato de liberación inmediata (MLI; Rubifen®) y el de liberación\nprolongada (MLP; Medikinet®, Concerta®) en el tratamiento del trastorno por déficit de",
60 "cited_by_count": 188,
61 "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
62 "versions_count": 4,
63 "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
64 },
65 {
66 "position": 4,
67 "title": "El impacto de la rehabilitación neuropsicológica en niños con TDAH",
68 "link": "http://dehesa.unex.es/handle/10662/6497",
69 "domain": "dehesa.unex.es",
70 "displayed_link": "AF Rodrigues - 2017 - dehesa.unex.es",
71 "snippet": "… La elección del tratamiento para el TDAH es la terapia de medicamentos, más específicamente\nmetilfenidato. Este componente se coloca en el mercado con los nombres comerciales de Ritalin\ny Rubifen … This component is marketed under the trade names Ritalin and Rubifen",
72 "cited_by_count": 188,
73 "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
74 "versions_count": 4,
75 "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
76 },
77 {
78 "position": 5,
79 "title": "[PDF][PDF] Correlación electroclínica diagnóstica y terapéutica con metilfenidato de acción inmediata en TDAH",
80 "link": "https://www.seinap.es/wp-content/uploads/Revista-de-Pediatria/2004/REP%2060-3.pdf#page=7",
81 "domain": "www.seinap.es",
82 "displayed_link": "JRV Usón - ás se rna, 2004 - seinap.es",
83 "snippet": "… la respuesta clínica. Con estos parámetros, las dosis de MPH de liberación inmediata\n(Rubifen®) que se administraron fueron entre 10 a 40 mg, repartidas en el desayuno\ny la comida, según ne- cesidad clínica. Dentro de la"
84 },
85 {
86 "position": 6,
87 "title": "Metilfenidato: actualización de las condiciones de uso:(Nota informativa de la AEMPS 2009/01, de 22 de enero de 2009)",
88 "link": "https://dialnet.unirioja.es/servlet/articulo?codigo=2961760",
89 "domain": "dialnet.unirioja.es",
90 "displayed_link": "LG Juan - Actualidad en farmacología y terapéutica, 2009 - dialnet.unirioja.es",
91 "snippet": "… En nuestro país, el metilfenidato está comercializado como formulaciones de liberación inmediata\n(Rubifen®) y de liberación prolongada (Concerta® y Medikinet cápsulas®). Fundación Dialnet.\nAcceso de usuarios registrados. Identificarse ¿Olvidó su contraseña? ¿Es nuevo"
92 },
93 {
94 "position": 7,
95 "title": "[PDF][PDF] ESTADO ACTUAL DEL ENFOQUE DEL TDAH EN NEUROPEDIATRIA",
96 "link": "https://eventos.emagister.com/_files/_event/_7507/_editorFiles/file/pon/CARDO,%20ESTHER.pdf",
97 "domain": "eventos.emagister.com",
98 "displayed_link": "E Cardo, G Ros, J Eiris, C Escofet, A Fernández-Jaén… - eventos.emagister.com",
99 "snippet": "… respecto a la medicación utilizada, la mayoría de los pacientes se encontraban bajo tratamiento\ncon algún tipo de metilfenidato de liberación prolongada (Equasym©, Medikinet© o Concerta©),\nun porcentaje estable utilizaban Metilfenidato de liberación inmediata (Rubifen"
100 },
101 {
102 "position": 8,
103 "title": "Implicación del farmacéutico comunitario en la dispensación a pacientes con trastorno por déficit de atención e hiperactividad. Un estudio piloto",
104 "link": "http://pharmcareesp.com/index.php/PharmaCARE/article/view/88",
105 "domain": "pharmcareesp.com",
106 "displayed_link": "MD Palomino, MJ Martín-Calero… - Pharmaceutical Care …, 2012 - pharmcareesp.com",
107 "snippet": "… Metilfenidato de liberación inmediata Rubifen® 5, 10, 20 mg Comprimidos de liberación inmediata\n2-3 veces al día Dosis de inicio: 5 mg Incrementos semanales de 5 mg/toma (hasta ajustar la\ndosis) Dosis diaria ≤60 mg Efecto inmediato, duración de 2-4 h tras cada toma"
108 },
109 {
110 "position": 9,
111 "title": "Effect of switching drug formulations from immediate-release to extended-release OROS Methylphenidate",
112 "link": "https://link.springer.com/article/10.2165/00023210-200822070-00005",
113 "domain": "link.springer.com",
114 "displayed_link": "JA Ramos-Quiroga, R Bosch, X Castells, S Valero… - CNS drugs, 2008 - Springer",
115 "snippet": "… Abstract. Background: The potential advantages of osmotic-release oral system (OROS)\nmethylphenidate (Concerta®) over immediate-release (IR) methylphenidate (Rubifen®) in adults\nwith attention-deficit hyperactivity disorder (ADHD), with respect to medication adherence"
116 },
117 {
118 "position": 10,
119 "title": "The impact of psychopedagogical intervention on quality of life in adolescents with attention deficit hyperactivity disorder (ADHD) treated with psychostimulant …",
120 "link": "https://www.cambridge.org/core/journals/european-psychiatry/article/impact-of-psychopedagogical-intervention-on-quality-of-life-in-adolescents-with-attention-deficit-hyperactivity-disorder-adhd-treated-with-psychostimulant-medication/76422BADEBE6B6BD3687DE0B51358A81",
121 "domain": "www.cambridge.org",
122 "displayed_link": "C Lima, D Rodrigues, M Silva, S Rego - European Psychiatry, 2017 - cambridge.org",
123 "snippet": "… plans. The aim of this study was to evaluate the impact of a psychopedagogical\nintervention on quality of life of a sample of adolescents with ADHD taking into account\ntheir pharmacologi- cal plans (rubifen, ritalin, and concerta)"
124 }
125 ],
126 "pagination": {
127 "current": 1,
128 "next": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48",
129 "other_pages": [
130 {
131 "page": 2,
132 "link": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48"
133 },
134 {
135 "page": 3,
136 "link": "https://www.google.com/scholar?start=20&q=rubifen&hl=en&as_sdt=0,48"
137 }
138 ],
139 "api_pagination": {
140 "next": "https://api.serpwow.com/live/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2",
141 "other_pages": [
142 {
143 "page": 2,
144 "link": "https://api.serpwow.com/live/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2"
145 },
146 {
147 "page": 3,
148 "link": "https://api.serpwow.com/live/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=3"
149 }
150 ]
151 }
152 },
153 "related_searches": [
154 {
155 "query": "text network analysis nursing",
156 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=1&q=text+network+analysis+nursing&qst=ib",
157 "type": "standard"
158 },
159 {
160 "query": "text network analysis gephi",
161 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=2&q=text+network+analysis+gephi&qst=ib",
162 "type": "standard"
163 },
164 {
165 "query": "text network analysis corpus studies",
166 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=3&q=text+network+analysis+corpus+studies&qst=ib",
167 "type": "standard"
168 },
169 {
170 "query": "text network analysis knowledge structure",
171 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=4&q=text+network+analysis+knowledge+structure&qst=ib",
172 "type": "standard"
173 },
174 {
175 "query": "text network analysis discourse bias",
176 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=5&q=text+network+analysis+discourse+bias&qst=ib",
177 "type": "standard"
178 },
179 {
180 "query": "text network analysis centrality",
181 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=6&q=text+network+analysis+centrality&qst=ib",
182 "type": "standard"
183 },
184 {
185 "query": "text network analysis public administration",
186 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=7&q=text+network+analysis+public+administration&qst=ib",
187 "type": "standard"
188 },
189 {
190 "query": "text network analysis kapucu",
191 "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=8&q=text+network+analysis+kapucu&qst=ib",
192 "type": "standard"
193 }
194 ]
195}